Partner with us
Collaborative partnerships support the CLSA to enrich the CLSA research platform, fostering its development into a dynamic, comprehensive, and invaluable resource for research on health and aging.
Partnerships can offer numerous benefits from accessing the rich CLSA dataset for high-quality research to facilitating the integration of robust research into policy, programs, services and products through capacity building and knowledge mobilization.
What the CLSA can offer
The CLSA seeks to develop collaborations with researchers and organizations to enhance the CLSA research platform and ensure its relevance to the most pressing issues affecting Canada’s aging population by supporting high-quality research, evidence-based decision-making, and translating knowledge into effective strategies to promote healthy aging and improve the quality of life for older adults.
Collaborative research opportunities
By working together with the CLSA, organizations can leverage and access CLSA’s one-of-a-kind comprehensive and longitudinal dataset, CLSA expertise, specialized analysis capabilities, and foster multidisciplinary approaches to enhance the quality and impact of research outcomes.
Access to CLSA infrastructure
Partners have the potential to tap into the CLSA research platform and its infrastructure, which includes fully equipped data collection facilities and call centres across Canada, data curation and laboratory and biobanking facilities.
Dissemination and knowledge mobilization
The CLSA is committed to knowledge translation and dissemination of research findings. Partners can collaborate by becoming knowledge users, engaging in the research process and sharing research outcomes, thereby maximizing the impact of research in informing policy, practice, and public understanding.
Partner Benefits
The value of the CLSA is unprecedented as it is the most comprehensive research platform with longitudinal and deeply characterized data. The CLSA is also the only population-based cohort in Canada with longitudinal collection of biological samples with associated clinical and health-care utilization data.
Partnering with the CLSA will enable high-quality research with a longitudinal perspective, availability of CLSA’s research infrastructure, and support outcomes and evidence to inform health and public policies, product and services and personalized medicine.
CLSA collaborations enable partners to:
Investigate risk of disease development using longitudinal multi-omics data.
Discover biomarkers and drug targets for pharmacotherapy and disease management.
Use of state-of-the-art facilities: Biorepository and Bioanalysis Centre, fully-equipped data collection facilities and call centres across Canada, Data Curation Centre, genetic and epigenetic centre.
Collaborate and harmonize with other national and international cohorts.
Study trajectories of healthy aging generate evidence to inform health and public policy.
Develop new services and products.
Study health-care utilization patterns.
Funders
Collaborators
CLSA Sponsors
- Actigraph LLC
- Affymetrix
- Aim Instrumentation
- Air Liquide Healthcare
- Alberta Precision Laboratories
- Alteeve
- Alteeve’s Niche!
- Audcomp Information
- Technology Solutions
- BD Canada
- Beckman Coulter
- Center for Molecular Medicine and Therapeutics
- Christie Innomed
- Dell Canada
- Eppendorf
- GA International
- GE Healthcare
- Canada
- High Purity Water
- Innova Medical
- IntegenX
- Interaxon
- JTECH Medical
- Labware Enterprise
- Laboratory Platform
- Leger Marketing
- Luminex Corp
- LVL Technologies
- Maelstrom
- Mandel Scientific
- Mantha Medical
- Marksal Communications
- McArthur Medical
- McGill University and Genome Quebec Innovation Center
- McMaster Innovation Park
- MedicalMart
- Millipore BioScience
- Mobvoi International Technology
- Nalge Nunc Matrix Technologies
- Net Access
- OCR Canada
- Pacer Digital Systems
- Perfect Sphere Productions
- Siemens Healthcare Ltd.
- Somagen Diagnostics
- Staples
- Stemcell Technologies Canada
- Tecan US Inc
- Telecom Computers
- The Centre of Applied Genomics
- The Hospital for Sick Children
- Thermo Fisher Scientific
- Tiger Direct
- Topcan Canada
- Vocantas Inc
- VWR International
“The Canadian Longitudinal Study on Aging is an amazing resource that measures a wide range of genetic, imaging and lifestyle factors that contribute to successful ageing, following individuals’ health trajectory over decades. This enables groundbreaking discoveries and saves huge amounts of time and money when testing or developing hypotheses. Using this data has enabled us to get a large grant exploring how a novel measure of blood vessel health develops and progresses over time as well as providing crucial insight into how we prevent this happening in the future.”
– Joshua Lewis